Valeant Pharma (VRX) Misses Dramatically Reduced Expectations - BMO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. CRGY
10. AAPL

Go back to Valeant Pharma (VRX) Misses Dramatically Reduced Expectations - BMO

Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information

March 15, 2016 6:00 AM EDT

Company Provides New 2016 Guidance

LAVAL, Quebec, March 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the "Company") today announced preliminary unaudited financial information for the fourth quarter 2015.

As a result of the ongoing work of the Company's Ad Hoc Committee of the Board of Directors appointed to review the Company's relationship with Philidor and related matters, and the Company's ongoing assessment of the impact of the committee's findings on financial reporting and internal controls, the unaudited fourth... More